Kevin K. Roggin to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Kevin K. Roggin has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.129
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.129